GILEAD SCIENCES, INC.
CIK: 882095
New Positions
0
Increased
0
Decreased
0
Exit Positions
0
Holdings (5)
Q3 2026 13F, quarter ended Sep 30, 2026, filed Nov 5, 2026
- RCUS
Arcus Biosciences Inc.
$811.7M
31.42M sh55.45%+0.0% - GLPG
Lakefront Biotherapeutics
$501.28M
16.71M sh34.24%+0.0% - ASMB
Assembly Biosciences Inc.
$116.91M
4.98M sh7.99%+0.0% - KYTX
Kyverna Therapeutics Inc.
$28.06M
4.13M sh1.92%+0.0% - XLO
Xilio Therapeutics Inc.
$5.89M
650,389 sh0.40%+0.0%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
 RCUS Arcus Biosciences Inc. | 31.42M | $811.7M | +0.0% | 55.45% | Q3 2026 |
 GLPG Lakefront Biotherapeutics | 16.71M | $501.28M | +0.0% | 34.24% | Q3 2026 |
 ASMB Assembly Biosciences Inc. | 4.98M | $116.91M | +0.0% | 7.99% | Q3 2026 |
 KYTX Kyverna Therapeutics Inc. | 4.13M | $28.06M | +0.0% | 1.92% | Q3 2026 |
 XLO Xilio Therapeutics Inc. | 650,389 | $5.89M | +0.0% | 0.40% | Q3 2026 |
1-5 of 5 holdings
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
About GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC. is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 882095). Signal8 holds 14 13F filings from it. Its SEC filings list Delaware as its state of incorporation.
Its most recent 13F holdings report covers Q3 2026 (the quarter ended Sep 30, 2026) and was filed on Nov 5, 2026. That report lists 5 securities, not counting options, the same number as in Q2 2026.
Its five largest reported positions, in order, are Arcus Biosciences Inc. (RCUS), Lakefront Biotherapeutics (GLPG), Assembly Biosciences Inc. (ASMB), Kyverna Therapeutics Inc. (KYTX) and Xilio Therapeutics Inc. (XLO).
Recent 13F filings by GILEAD SCIENCES, INC.
- Q3 2026: 13F-HR filed Nov 5, 2026, listing 5 securities.
- Q2 2026: 13F-HR filed Aug 3, 2026, listing 5 securities.
- Q1 2026: 13F-HR filed May 7, 2026, listing 6 securities.
- Q4 2025: 13F-HR filed Feb 12, 2026, listing 6 securities.
- Q3 2025: 13F-HR filed Nov 13, 2025, listing 9 securities.
- Q2 2025: 13F-HR filed Aug 14, 2025, listing 14 securities.